Skip to main navigation Skip to search Skip to main content

High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers

  • Kristiina Iljin
  • , Paula Vainio
  • , Kirsi Ketola
  • , M. Björkman
  • , Pekka Kohonen
  • , John Mpindi
  • , Vidal Fey
  • , T. Mirtti
  • , K. Alanen
  • , Merja Perälä
  • , Olli Kallioniemi

    Research output: Contribution to conferenceConference articleScientific

    Original languageEnglish
    Publication statusPublished - 2010
    MoE publication typeNot Eligible
    EventBIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010 - Beijing International Convention Center, Beijing, China
    Duration: 23 Oct 201026 Oct 2010

    Conference

    ConferenceBIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010
    Country/TerritoryChina
    CityBeijing
    Period23/10/1026/10/10

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this